| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |